EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review

Liru Chen iD, Chuhan Zhang, Ruixuan Niu, Shanshan Xiong, Jinshen He iD, Yu Wang, Pingxin Zhang, Fengyuan Su, Zishan Liu iD, Longyuan Zhou, Ren Mao, Shixian Hu und 3 weitere

United European Gastroenterology Journal · 2025-05 · 13 (4) · 517-530

DOI: 10.1002/ueg2.12720 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift United European Gastroenterology Journal, online erschienen am 10.12.2024. Verfasst von Liru Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Biological Products, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heterogeneity and suboptimal efficacy of biological treatments and small molecule drugs necessitate their precise selection based on biomarkers that predict therapeutic responses in inflammatory bowel disease. Recent studies have identified numerous novel biomarkers predictive of responses to biologics and small molecule modulators, utilizing a variety of omics approaches in inflammatory bowel disease. In this review, we systematically examine baseline omics biomarkers that predict responses to biological therapies and small molecule drugs, drawing on literature from PubMed. Our analysis spans multiple omics disciplines, including genomics, transcriptomics (both bulk RNA and single‐cell RNA sequencing), proteomics, microbiomics, and metabolomics, with particular emphasis on the impact of models integrating multiple omics datasets. Additionally, to further the field of precision medicine, we evaluated specific biomarkers that may exhibit distinct effects on responses to multiple therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsInflammatory Bowel DiseasesAdultHumansBiomarkersGenomicsMetabolomicsMultiomicsPrecision MedicineProteomicsTranscriptomeTreatment Outcome

Stichwörter der Autor:innen

Crohn's diseaseadalimumabcertolizumabinflammatory bowel diseaseinfliximabprecision medicinetofacitinibulcerative colitisustekinumabvedolizumab

Substanzen

Biological ProductsBiomarkers

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangxi Hospital Division, The First Affiliated Hospital, Sun Yat-sen University, Nanning, China.

ORCID-Profile: Liru Chen, Jinshen He, Zishan Liu, Rui Feng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • National Key Research and Development Program of China

Zitieren

APA

Chen, L., Zhang, C., Niu, R., Xiong, S., He, J., Wang, Y., Zhang, P., Su, F., Liu, Z., Zhou, L., Mao, R., Hu, S., Chen, M., Qiu, Y., & Feng, R. (2025). Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review. United European Gastroenterology Journal, 13(4), 517-530. https://doi.org/10.1002/ueg2.12720

Vancouver

Chen L, Zhang C, Niu R, Xiong S, He J, Wang Y, et al. Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review. United European Gastroenterology Journal. 2025;13(4):517-530. doi:10.1002/ueg2.12720

BibTeX
@article{Chen2025,
  author = {Chen, Liru and Zhang, Chuhan and Niu, Ruixuan and Xiong, Shanshan and He, Jinshen and Wang, Yu and Zhang, Pingxin and Su, Fengyuan and Liu, Zishan and Zhou, Longyuan and Mao, Ren and Hu, Shixian and Chen, Minhu and Qiu, Yun and Feng, Rui},
  title = {Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {4},
  pages = {517--530},
  doi = {10.1002/ueg2.12720}
}
Kostenlos starten →